(This content is being used for illustrative purposes only; any person depicted in the content is a model)
Author: Shernide Delva
Another devastating tragedy in music occurred on Thursday.
Chester Bennington, the lead singer of Linkin Park, was found dead at just 41 years old due to an apparent suicide. Brian Ellis, the chief of operations for the LA County coroner’s office, confirmed the death hours after it was reported by a TMZ article.
The death struck similarities to the death of Sound Garden frontman Chris Cornell, who killed himself in May. Chester Bennington was very close to Cornell, and his suicide occurred on Cornell’s birthday.
On the day of Chris Cornell’s suicide, Bennington wrote an open letter expressing his grief.
“I can’t imagine a world without you in it,” he wrote.
“I pray you find peace in the next life.”
The Era of Linkin Park
Linkin Park had a string of mega-hits over the years, including “Faint,” “In the End” and “Crawling.” Linkin Park even crossed music genres, collaborating with Jay-Z. The Linkin Park album, “Meteora,” was one of the biggest alternative albums in music history.
The death is a shock to millions of fans; however, Chester Bennington’s struggle with addiction and mental illness is not something he was ever private about. Bennington has opened up various times throughout his career about his struggles with substance abuse and mental illness.
In a recent interview, Bennington elaborated on what he had to overcome over the past few years. In 2015, Bennington broke his ankle while playing basketball. The ankle injury forced the band to cancel all of the tour dates they had remaining for The Hunting Party Tour that year.
Stone Temple Pilot guitarist, Dean Deleo, talked with radio station WAAF-FM about how severe the injury was:
“He hurt himself badly. It was not only a break — the guy tore darn near every ligament in his ankle,” DeLeo says to host Mistress Carrie. “They had to go in on each side. He has about a five-inch incision on each side. They had to go in and assemble a big bowl of spaghetti.”
Talks of Depression and Addiction Issues
In May of this year, Bennington talked about how his ankle injury took a significant toll on his life.
“I needed reconstructive surgery and like plates and screws and more surgery,” he says. “It was like ‘wow.’ It was nasty, and that took me into a depression.”
Bennington says he started falling into bad habits due to the severity of the injury.
“I got to a point where I was like medicating, kind of having issues with that, kind of like falling into old habits, into old behaviors.”
This was not Bennington’s first injury. He says injuries have been an ongoing part of his life since 30. He described it as a tumultuous cycle of rehabbing injuries, reinjuring himself, and undergoing multiple surgeries.
Along with the stress of his injuries, the hardships of life continued to take their toll.
“Being in Linkin Park, it has a lot of perks, and it’s really a fun life, and it’s a blessed life. I get to do what I do with really talented exceptionally decent people,” he says.
“At the same time like none of us are immune from just sh*t happening to you and not to you but just making poor choices or being human. There’s always that element.”
Bennington talked about the band’s newest single “Heavy” and the challenges that inspired the song. He explains in the interview how problems started to stack one on top of the other.
“Life got really weird and really hard all at one time,” he says.
“It was like one of our friends died from cancer, my step dad died of cancer. I broke my leg and had to rehab that for a year. I quit Stone Temple Pilots because it was just too much. I felt bad about that, and then I was depressed and drinking again and doing all this stuff and I was like ‘Dude, this is crazy.’”
“I even told one of my therapists at one point that I just don’t want to feel anything,” he admits.
On Surrendering Control:
Although Bennington talks about his struggles throughout the interview, he remains positive. He learned to surrender to life instead of always having to be in control.
“I find myself personally when I’m stuck, it’s because I haven’t just surrendered to the process of life. I’m trying to like be in there and do things my way. I’m trying to steer the ship or whatever,” he says, “There were a few times over the last couple years when I was ready to throw in the towel and give up on everything.”
The band was promoting their new album and tour and had dates set for the rest of the year.
Bennington is survived by six children and his wife, model Talinda Ann Bentley.
“I came to a point in my life where I was like, ‘I can either just give up and f—ing die or I can f—ing fight for what I want.’ And I chose to fight for what I wanted,” he says in the interview obtained by The Mirror. “I wanted to have good relationships. I wanted to love the people in my life. I wanted to enjoy my job.”
As a long-time fan of Linkin Park, I was devastated by the news of his death. Mental illness and addiction were challenges that plagued the singer’s life for decades. Still, in recent interviews, Bennington appeared to be making progress.
However, this simply confirms how serious mental illness is. It is not something that is easily understood, and none of us really know what pushed Chester Bennington to his breaking point. Regardless, the stigma has to stop. If you or anyone you know is struggling with mental illness, please reach out. There is help out there. Call now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
Big Pharma has been called out several times in the past couple years for pricing, aggressive marketing and misrepresenting their products. Big Pharma companies have also been called to court a few times for the contribution prescription opioid drugs have made on the opioid epidemic that has damaged the country. The financial and emotional toll of the opioid epidemic has hit hard in several states. South Florida is no exception. Delray Beach has experienced their fair share of strain from the opioid problem, especially when it had been an epicenter of the huge illegal pill mill problem.
Now community leaders in Delray Beach are seeking restitution from the Big Pharma empires, making it the first city in Florida to take this shot at holding Big Pharma accountable.
The Big Suit
That’s why the Delray Beach commission Tuesday decided to sue drug makers for the part they played in the heroin crisis. The city has enlisted the national law firm of Robbins Geller Rudman & Dowd from their office based in Boca Raton. So far the suit has set its sights on at least 8 major drug makers and distributors. Two of these have already seen similar cases; Purdue Pharma and McKesson Corp.
Mayor of Delray Beach, Cary Clickstein, has stated:
“With virtually no help from our federal government and little from our state … cities like ours are now frantically searching for answers for our own population,”
“We’re right for turning our eyes to those who are known conspirators in this ongoing atrocity.”
According to the law firm representing Delray Beach, the Big Pharma companies being pursued are responsible for:
- Downplaying the addictive nature of opioids
- Forcing the burden of dealing with the resultant overdoses on state, county and city governments
One of the more impressive features of this case is that the lawsuit won’t cost the city of Delray Beach. The expenses will be covered by Robbins Geller. However, the case supposedly has the potential to garner millions in damages for the parties pressing the matter.
According to a partner of the law firm, who compared the Big Pharma tactics to the now infamous tactics of Big Tobacco,
“They went out and said that opioids are less than 1 percent addictive. That is obviously not true.”
The Mayor and the law firm seem hopeful, while other states have been laying the groundwork for these powerful fights.
States VS Big Pharma
Back in 2015, two counties in California sought damages against 5 Big Pharma companies for the same reasons, and in no time at all the case had been dismissed. However, recently one of these drug company agreed to pay 1.6 million for substance abuse treatment to settle the lawsuit. 4 others remain as defendants in this ongoing battle.
In 2014, Chicago’s Mayor Rahm Emanuel took a similar stance, but in 2015 the case was also dismissed. However, the court did state in one of these cases:
“The Purdue entities made misstatements about opioids on their own websites with the intention that Chicago doctors and consumers rely on those misrepresentations are sufficient to state claims against the Purdue entities for violations…”
And while U.S. District Judge Jorge L. Alonso dismissed many of the complaints, the battle over whether these companies deliberately misrepresented the drug benefits and risks continues.
Even recently Ohio Attorney General Mike DeWine announced the state is suing 5 pharmaceutical companies, including:
- Purdue Pharma
- Endo Health Solutions
- Teva Pharmaceutical Industries and subsidiary Cephalon
- Johnson & Johnson and subsidiary Janssen Pharmaceuticals
- Allergan, formerly known as Actavis
There are numerous other suits that have been filed against Big Pharma companies.
- Four counties in New York
- The Cherokee Nationfiled a lawsuit against distributors and pharmacies in tribal court over the opioid epidemic.
- The city of Everett, Washington
While some of these suits may go over better than others, the fact is Big Pharma is under some serious scrutiny.
Delray Beach Making a Case
The Delray Beach lawsuit will seek damages based on the claims that drug makers and distributors violated laws of:
- State consumer protection
- Public nuisance
- Unjust enrichment
According to city officials, every overdose in Delray Beach costs the city about $2,000 in manpower and lifesaving materials. With 690 overdoses last year, that puts the bill around $1,380,000. The only problem is finding a way to prove that pharmaceutical companies can be linked to these overdoses. While many, if not all, of those overdoses were heroin-related, the city may still have grounds to go after opioid drug makers in Big Pharma because these dangerous drugs are considered an underlying problem in the opioid epidemic.
Between 72 and 82 opioid prescriptions are written for every 100 people in Florida, the law firm reports.
While the law firm anticipates other governing bodies will join as plaintiffs, Delray Beach leaders insist they will not wait for other plaintiffs to join the lawsuit. At this point there is not telling how long the lawsuit will last.
There should definitely be accountability for the damage that has been done thanks to the misrepresentation of drug risks and benefits. The misguided and underestimated use of powerful opioids has destroyed countless lives over the years. But beyond holding Big Pharma accountable, there should also be some effort put forth by the state and community officials to promote safe and effective addiction treatment. Innovative and holistic recovery programs can make a huge impact. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-800-951-6135
Author: Shernide Delva
Each year, more than 300 million people are affected by depression. Depression is a debilitating illness that is difficult to treat.
What if there was one gene that played a key role in depression? Furthermore, what if that gene could be identified and even manipulated to actually treat depression?
Shockingly, this could all be a possibility. Researchers have discovered a gene that may play a central role in depression. This gene either protects us from stress or triggers a downward spiral depending on its level of activity.
The study was conducted by researchers at the University of Maryland School of Medicine (UM SOM). It was the first to pinpoint in detail how one particular gene, known as Slc6a15, is a key role in depression. The study found the same link in both animals and humans.
“This study really shines a light on how levels of this gene in these neurons affects mood,” said the senior author of the study, Mary Kay Lobo, an assistant professor in the Department of Anatomy and Neurobiology.
“It suggests that people with altered levels of this gene in certain brain regions may have a much higher risk for depression and other emotional disorders related to stress.”
Potential Treatment Solution?
A study like this could help with treating depression in the future, and that help is desperately needed.
Nearly 800,000 people die annually from suicide. It is the second leading cause of death among people between the ages of 15 to 29. Beyond that, depression destroys the quality of life for tens of millions of patients, and their families suffer too. Although environmental factors play a significant role in many cases of depression, genetics are equally as important.
This is not the first time this gene was studied. Back in 2006, Dr. Lobo and her colleagues found that the Slc6a15 gene was common in specific neurons in the brain. They recently demonstrated that these neurons were important in depression.
Connection to Anhedonia
Her lab decided to investigate the specific role these neurons have in depression. In the latest study, she and her team focused on a particular area of the brain called the nucleus accumbens. This region is crucial in the brain’s “reward circuit.”
When you eat a delicious meal or participate in any kind of enjoyable experience, neurons in the nucleus accumbens are activated letting you know the experience is enjoyable. When a person is depressed, it ‘s hard to experience any kind of enjoyment, a condition known as anhedonia.
Researchers discovered subset neurons in the nucleus accumbens called D2 neurons. These neurons respond to the neurotransmitter dopamine, which plays a central role in the reward circuit.
Mainly, these subset neurons responded to feel good chemicals like dopamine which is lacking in those with depression. Next, they studied mice susceptible to depression. These mice tended to withdraw from activities and exhibit behavior indicating depression such as social withdrawal and lack of interest in the food they would normally enjoy.
Dr. Lobo found that when the mice were subject to social stress, the levels of the Slc6a15 gene in the D2 neurons of the nucleus accumbens was noticeably reduced. The researchers also studied mice in which the gene had been reduced in D2 neurons. When those mice were subjected to stress, they also exhibited signs of depression. Furthermore, when researchers increased the levels of Slc6a15 levels in D2 neurons, the mice showed a resilient response to stress.
So what does this mean?
Next, Dr. Lobo looked at brains of humans who had a history of major depression and who had committed suicide. In the same region of the brain as the mice, the gene Slc6a15 was reduced. This indicates that the link between gene and behavior is found in both humans and mice.
In the future, manipulating these genes could help improve depression. While it is still unclear how Slc6a15 operates in the brain, Dr. Lobo states it may work by altering neurotransmitter levels in the brain.
This research could lead to therapies that focus specifically on this particular gene to treat depression. If you are struggling with substance abuse or mental illness, call now. Do not wait.
CALL NOW 1-800-951-6135
Author: Shernide Delva
In the past, we’ve talked about the effects opioids have had on the workforce. We’ve analyzed issues such as how employers handle addiction and how to take time off to seek treatment.
However, a recent article delved further into the complications opioid use have on the workforce.
What if I told you that fewer people were looking for a job or had a job because of opioid addiction?
It turns out, this is a real possibility.
Workforce participation is defined as the number of people working or actively looking for work. Workforce participation has decreased significantly, despite increases in job creation and decreases in unemployment.
One economist points out this decrease may be due to an unlikely cause: opioid addiction.
“Use of both legal prescription pain relievers and illegal drugs is part of the story of declining prime-age participation, especially for men, and this reinforces our doubts about a rebound in the participation rate,” said David Mericle, senior U.S. economist at Goldman Sachs, who prepared a report on the issue earlier this week.
This belief is contrary to recent CBS reports which noted that the decline in workplace participation was due to less demand for lower skilled workers and rising disability rates.
On the contrary, David Mericle argues the reduction in workplace participation has more to do with opioid abuse.
“Data on substance abuse treatment episodes also reinforce the narrative: Of admissions of individuals not in the labor force, 58% described themselves as being out of the labor force for ‘other’ reasons—meaning they aren’t students, disabled, retired, inmates or homemakers—and 47% of these admissions were for opioids, well above the average rate,” he wrote in the report.
This issue simply cannot be ignored.
The opioid crisis has a clear impact on workplace participation because those who struggle with opioid addiction may quit their jobs or get fired. Then, those same people will not apply for other jobs due to their concerns regarding their ability to meet the demands of the work or even pass a drug screening.
“Especially in companies that hire drivers, we hear a lot about how the drug tests are a problem there,” Gad Levanon, chief economist for North America of The Conference Board told CBS. “Many of [the applicants] don’t pass it, so they can’t hire them—and they don’t know many aren’t even trying.”
Opioid abuse is rampant in the same demographic that has seen the largest decline in workforce participation. Opioid use is prevalent in rural areas which commonly struggle economically. A report stated that 22 out of 25 most impacted by opioid abuse are in rural areas or the South.
Which Came First: Economic Hardships or Opioid Abuse?
Mericle did not elaborate on how economic hardships may have influenced opioid abuse in these rural areas or vice versa. He concluded that the opioid epidemic “is intertwined with the story of declining prime-age participation, especially for men.” Essentially, it is hard to determine what led to what.
What do you think? Should we blame the decrease in workforce participation on opioid abuse or do other factors play a more significant role? Regardless of the effect opioids have on the workforce, the reality remains that it is a serious problem.
People who struggle with addiction often quit their jobs, or refuse to look at all because of their addiction. Therefore, a push for treatment is critical. If you are struggling with substance abuse or mental illness, call now. Do not wait.
CALL NOW 1-800-951-6135
Author: Shernide Delva
True Blood star Nelsan Ellis passed away from heart failure due to attempting to detox from alcohol on his own. The 39-year-old actor is best known for his role as Lafayette Reynold’s on the HBO hit. Reports originally stated the actor’s death was due to heart complications. No other details were stated. However, days later the actor’s family opened up about the cause of death as a “cautionary tale” to help others.
Rather than shy away, the family of Nelsan Ellis revealed that it was a long battle with alcoholism that ultimately led to Ellis’ death.
The Illinois-born actor studied at the prestigious New York performing arts school Juilliard and played the role of Lafayette on True Blood from 2008-2014. More recently, he was working on the CBS detective series Elementary.
Prior to his death, Ellis was attempting to quit drinking. According to the reports, Ellis felt shame about his drinking and had already gone to rehab a few times before. Therefore, he decided to hide his drinking and quit on his own.
Detoxing from alcohol without medical supervision can result in a variety of medical issues including heart failure.
Warning: Alcohol Withdrawals are Deadly!
It is so important others learn from Ellis’ mistake to stop drinking on his own. Many people are unaware of how severe alcohol withdrawals are. In fact, alcohol withdrawals are more dangerous than any other drugs, even prescription painkillers, and heroin.
In severe cases alcohol withdrawals can result in:
- Severe tremors
- Racing heartbeat
- High blood pressure
- Brain Damage
Alcohol leads to more deaths than all other drugs combined. The National Institute on Alcohol Abuse and Alcoholism (NIAA) estimates that alcohol causes 88,000 deaths every year.
Nelsan Ellis’ Family Comes Forward to Help Others
It was very brave of the family to come forward with the reality of their loved one’s condition. The original news reports released after the actor’s death did not mention anything regarding the actor’s alcoholism. It would have been extremely easy for the family not to say anything and go along with the reports
Instead, they released a statement so that others struggling with alcoholism know the importance of seeking treatment before it is too late.
“Nelsan has suffered with drug and alcohol abuse for years,” the actor’s manager said on behalf of the family.
“After many stints in rehab, Nelsan attempted to withdraw from alcohol on his own. According to his father, during his withdrawal from alcohol he had a blood infection, his kidneys shut down, his liver was swollen, his blood pressure plummeted, and his dear sweet heart raced out of control.”’
“On the morning of Saturday, July 8th, after four days in Woodhull Hospital, Nelsan was pronounced dead. Nelsan was a gentle, generous and kind soul…Nelsan was ashamed of his addiction and thus was reluctant to talk about it during his life. His family, however, believes that in death he would want his life to serve as a cautionary tale in an attempt to help others.”
From the statement, it is evident the family decided to make the death of their loved one a warning to others. Many addicts would rather hide in shame or attempt to detox on their own instead of getting the help they desperately need.
Alcohol withdrawals vary from person to person, and for some, detoxing without medical supervision is highly risky. Individuals may experience what is known as delirium tremens (DTs) characterized by disorientation, severe agitation, rapid heartbeat, high blood pressure, and fever.
DTs can last up to 3 or 4 days, according to Dr. Richard Saitz in “Introduction to Alcohol Withdrawal,” a paper published on the website of the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
“About 5% of patients who experience DTs die from metabolic or cardiovascular complications, trauma or infections,” Saitz state.
One should never detox on their own.
This unfortunate death serves as a message to those considering withdrawing from drugs on their own. Don’t do it. The detox process should be monitored by medical professionals that can provide the tools needed to do so safely.
Overall, we must commend Nelsan Ellis’ family for choosing to come forward about the adored actor’s condition. The stigma of addiction prevents addicts from seeking treatment. Do not try to fight your addiction on your own. Instead, call today. We are waiting for your call.
CALL NOW 1-800-951-6135